Nanomaterials for cancer immunotherapy

W Song, SN Musetti, L Huang - Biomaterials, 2017 - Elsevier
Cancer immunotherapy is quickly growing to be the fourth most important cancer therapy,
after surgery, radiation therapy, and chemotherapy. Immunotherapy is the most promising …

[HTML][HTML] COVID-19 and cancer comorbidity: therapeutic opportunities and challenges

AS Pathania, P Prathipati, BAA Abdul, S Chava… - Theranostics, 2021 - ncbi.nlm.nih.gov
Abstract The coronavirus disease 2019 (COVID-19) is a viral disease caused by a novel
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that affects the respiratory …

[HTML][HTML] Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs

S Seneff, G Nigh, AM Kyriakopoulos… - Food and Chemical …, 2022 - Elsevier
Abstract The mRNA SARS-CoV-2 vaccines were brought to market in response to the public
health crises of Covid-19. The utilization of mRNA vaccines in the context of infectious …

Harnessing the immune system against cancer: current immunotherapy approaches and therapeutic targets

AR Kumar, AR Devan, B Nair, BS Vinod… - Molecular biology …, 2021 - Springer
Cancer immunotherapy is a rapidly evolving concept that has been given the tag" fifth pillar"
of cancer therapy while radiation therapy, chemotherapy, surgery and targeted therapy …

Advances and applications of chitosan-based nanomaterials as oral delivery carriers: A review

X Lang, T Wang, M Sun, X Chen, Y Liu - International journal of biological …, 2020 - Elsevier
The oral drug administration was convenient and comfortable route for patients.
Nevertheless, the oral uptake efficiency of many therapeutic agents was limited by …

[PDF][PDF] Renal cell carcinoma: Review of etiology, pathophysiology and risk factors.

N Petejova, A Martinek - … Papers of the Medical Faculty of …, 2016 - biomed.papers.upol.cz
Methods. A literature search using the databases Medscape, Pubmed, UpToDate and
EBSCO from 1945 to 2015. Results and Conclusions. Genetic predisposition/hereditary …

Engineering strategies for immunomodulatory cytokine therapies: challenges and clinical progress

IS Pires, PT Hammond, DJ Irvine - Advanced therapeutics, 2021 - Wiley Online Library
Cytokines are immunoregulatory proteins involved in many pathological states with
promising potential as therapeutic agents. A diverse array of cytokines has been studied in …

[HTML][HTML] Origen, características estructurales, medidas de prevención, diagnóstico y fármacos potenciales para prevenir y controlar COVID-19

NF Santos-Sánchez, R Salas-Coronado - Medwave, 2020 - viejo.medwave.cl
El síndrome respiratorio agudo severo coronavirus 2 (SARS-CoV-2) es responsable de la
enfermedad denominada COVID-19 (acrónimo del inglés Coronavirus Disease-2019). Esta …

New strategies using antibody combinations to increase cancer treatment effectiveness

I Corraliza-Gorjón, B Somovilla-Crespo… - Frontiers in …, 2017 - frontiersin.org
Antibodies have proven their high value in antitumor therapy over the last two decades.
They are currently being used as the first-choice to treat some of the most frequent …

Development of a drug delivery system based on chitosan nanoparticles for oral administration of interferon-α

C Cánepa, JC Imperiale, CA Berini, M Lewicki… - …, 2017 - ACS Publications
Despite the good clinical efficacy of interferon-alpha (IFNα) to treat some types of cancer and
viral infections, this biological drug is underused given its severe adverse effects and high …